First European Completed Case with ihtObtura®, a Novel Liquid Embolic Agent with Radiopacity Loss
Journal of Neurointerventional Case Reports · 2025
DOI: 10.70355/nicer.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurointerventional Case Reports, 2025. Verfasst von Juan Carlos Llibre-Guerra und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A middle-aged patient with an intracranial hemorrhage was diagnosed with a pareto-occipital arteriovenous malformation (AVM). After decompressive surgery, the patient was scheduled for delayed embolization with curative intention. ihtObtura®, a novel liquid embolic agent with radiopacity loss, was selected as optimal treatment to avoid multi-stage radiopacity cast residues that hinder visualization and 3D vasculature reconstruction. AVM was occluded after 3 endovascular sessions without treatment-related side effects. The potential extensive use of this novel material with radiopacity loss will probably enhance the knowledge of intravascular embolization of complex lesions with curative intention.
Zitieren
APA
Llibre-Guerra, J. C., Heras, J. A. D. L., Vargas, L., Gil, A., Guimaraens, L., & Castaño, M. Á. (2025). First European Completed Case with ihtObtura®, a Novel Liquid Embolic Agent with Radiopacity Loss. Journal of Neurointerventional Case Reports. https://doi.org/10.70355/nicer.3
Vancouver
Llibre-Guerra JC, Heras JADL, Vargas L, Gil A, Guimaraens L, Castaño MÁ. First European Completed Case with ihtObtura®, a Novel Liquid Embolic Agent with Radiopacity Loss. Journal of Neurointerventional Case Reports. 2025. doi:10.70355/nicer.3
BibTeX
@article{LlibreGuerra2025,
author = {Llibre-Guerra, Juan Carlos and Heras, José Antonio De las and Vargas, Luis and Gil, Alberto and Guimaraens, Leopoldo and Castaño, Miguel Ángel},
title = {First European Completed Case with ihtObtura®, a Novel Liquid Embolic Agent with Radiopacity Loss},
journal = {Journal of Neurointerventional Case Reports},
year = {2025},
doi = {10.70355/nicer.3}
}
EUVIMED